HMP Global

Oncology Learning Network

Podcast by HMP Global

Vizitează neapărat site-ul podcastului și susține-i creatorul: soundcloud.com

Autor

HMP Global

Categorie

Health

Site-ul podcastului

soundcloud.com

Cel mai nou episod

4 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

Sarcoma Sound Bites with Brian and Bob: Exploring the Territory of TGCT (Part 1) 23.04.2020

In this inaugural episode of Sarcoma Sound Bites with Brian and Bob, an Oncology Learning Network Podcast, join Brian Van Tine, MD, PhD, Sarcoma Program Director, Washington University, and Robert “Bob” Maki, MD, PhD, Northwell Health Cancer Center Institute, New York, as they discuss the challenges of treating tenosynovial giant cell tumors (TGCTs), and how the treatment landscape for TGCT has ev...

Treating Lung Cancer in the COVID-19 Climate 08.04.2020

Joshua M. Bauml, MD, Assistant Professor of Medicine at the Hospital of the University of Pennsylvania, Philadelphia, shares first-hand insight on the management of patients with lung cancer during the COVID-19 pandemic.

Impact of Text Messaging on Therapy Adherence in Patients With Breast Cancer 31.03.2020

In an interview with Oncology Learning Network, Julie R. Gralow, MD, Clinical Director, Breast Medical Oncology, Seattle Cancer Care Alliance, Washington, talks about the clinical significance and findings of the SWOG S0307 trial.

Improving Logistics to Encourage Patient Enrollment in Cancer Clinical Trials 31.03.2020

In an interview with Oncology Learning Network, Julie R. Gralow, MD, Clinical Director, Breast Medical Oncology, Seattle Cancer Care Alliance, Washington, discusses ways that healthcare providers can encourage patient enrollment in cancer clinical trials.

Fractures and the Use of Bisphosphonates in Patients With Breast Cancer 30.03.2020

Julie R. Gralow, MD, Clinical Director, Breast Medical Oncology, Seattle Cancer Care Alliance, Washington, discusses findings from the SWOG S0307 trial, which looked at the occurrence of fractures in patients with breast cancer receiving high-dose bisphosphonates to prevent metastases.

Michiel Van de Sande, MD, Discusses Multidisciplinary Approach to Treating TGCT 30.03.2020

Michiel Van de Sande, MD, Discusses Multidisciplinary Approach to Treating TGCT by HMP Global

Post-Transplant TKI Salvage Therapy Provides Significant Survival Benefit Following Relapse in CML 23.03.2020

Post-Transplant TKI Salvage Therapy Provides Significant Survival Benefit Following Relapse in CML by HMP Global

BTK Inhibitors Important in the Treatment Landscape of MCL 23.03.2020

BTK Inhibitors Important in the Treatment Landscape of MCL by HMP Global

ACCC President Talks Community Oncology and Bridging the Research Gap 18.03.2020

In an interview with Oncology Learning Network, Randall A. Oyer, MD, Association of Community Cancer Centers (ACCC) President, discusses the basis and goal of his presidency theme, entitled “Community Oncology Can Close the Gap in Cancer Research.”

Direct-to-Patient Strategies in Multiple Myeloma Care 13.03.2020

Direct-to-Patient Strategies in Multiple Myeloma Care by HMP Global

Kevin Kalinsky, MD, MS, Talks About the Importance of Gene-Profiling for Early-Stage Breast Cancer 09.03.2020

In an interview with Oncology Learning Network, Kevin Kalinsky, MD, MS, Herbert Irving Associate Professor of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, discussed why gene profiling plays such an important role in the management of patients with early-stage breast cancer.

Non-Chemotherapy Approach Induces High Rate of Undetectable MRD in CLL 27.02.2020

Non-Chemotherapy Approach Induces High Rate of Undetectable MRD in CLL by HMP Global

KTE-X19 Shows Great Efficacy in Heavily Pretreated MCL 25.02.2020

KTE-X19 Shows Great Efficacy in Heavily Pretreated MCL by HMP Global

SEQUOIA Trial: No Clinical Benefit Adding Pegilodecakin to FOLFOX for Pancreatic Cancer 24.02.2020

Joel Randolph Hecht, MD, David Geffen School of Medicine, University of California Los Angeles, shares findings from the SEQUOIA clinical trial of GEM-refractory pancreatic adenocarcinoma, an overview of recent studies and therapy options for metastatic pancreatic cancer, and what he believes may be the way forward to improve treatment outcomes in this patient population.

Matt Kalaycio, MD, Discusses the Historical Treatment of CML 24.02.2020

Matt Kalaycio, MD, Discusses the Historical Treatment of CML by HMP Global

Belantamab Mafodotin Demonstrates Promising Safety and Efficacy for MM 20.02.2020

Belantamab Mafodotin Demonstrates Promising Safety and Efficacy for MM by HMP Global

Front-Line Ibrutinib Plus Venetoclax Effective for CLL Irrespective of Patient Age 20.02.2020

Front-Line Ibrutinib Plus Venetoclax Effective for CLL Irrespective of Patient Age by HMP Global

Marginal Zone Lymphoma: Biology and Treatment 19.02.2020

Marginal Zone Lymphoma: Biology and Treatment by HMP Global

Ruxolitinib-BET Inhibitor Combo Promising for Myelofibrosis 14.02.2020

Ruxolitinib-BET Inhibitor Combo Promising for Myelofibrosis by HMP Global

iFCG Regimen Effective for Young, Fit Patients With IGHV-Mutated CLL 07.02.2020

iFCG Regimen Effective for Young, Fit Patients With IGHV-Mutated CLL by HMP Global

Scalp Cooling Device Lowers Risk for Chemo-Related Hair Loss, Gives Patients With Cancer Control 28.01.2020

In an interview with Oncology Learning Network, Michelle Melisko, MD, University of California San Francisco, and Melissa Bourestom, Dignitana, discussed the background, benefits, and future potential of the DigniCap Scalp Cooling System, which minimizes hair loss from certain chemotherapy treatments in patients with cancer.

Novel ABL1 Kinase Inhibitor Active in Heavily Pretreated CML 25.01.2020

Novel ABL1 Kinase Inhibitor Active in Heavily Pretreated CML by HMP Global

Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS in Treatment-Naïve CLL 24.01.2020

Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS in Treatment-Naïve CLL by HMP Global

Pacritinib Promising for Patients With Myelofibrosis and Severe Thrombocytopenia 21.01.2020

Pacritinib Promising for Patients With Myelofibrosis and Severe Thrombocytopenia by HMP Global

Mark Pegram, MD, Discusses the HER2CLIMB Trial and the Promising Nature of Tucatinib Therapy 10.01.2020

Dr Pegram, Associate Director for Clinical Research, Stanford Comprehensive Cancer Institute, Palo Alto, California, spoke with Oncology Learning Network about the basis, findings, and clinical significance of the HER2CLIMB clinical trial examining the use of tucatinib therapy in patients with HER2-positive breast cancer.

Ascultă podcastul Oncology Learning Network în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice